Exact Mass: 429.21268160000005
Exact Mass Matches: 429.21268160000005
Found 195 metabolites which its exact mass value is equals to given mass value 429.21268160000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Guan-fu base A
Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2]. Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2].
Sarpogrelate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
2-amino-3-[[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid
C21H35NO6S (429.21849700000007)
(-)N-(12-Acetoxy)jasmonoyl-phenylalaninmethylester
acehytisine
Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2]. Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2].
C21H35NO6S_Cysteine, S-[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxooxacyclotetradeca-6,9-dien-4-yl]
C21H35NO6S (429.21849700000007)
2-amino-3-[[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid_major
C21H35NO6S (429.21849700000007)
Ala Asp Lys Pro
Ala Asp Pro Lys
Ala Lys Asp Pro
Ala Lys Pro Asp
Ala Pro Asp Lys
Ala Pro Lys Asp
Asp Ala Lys Pro
Asp Ala Pro Lys
Asp Lys Ala Pro
Asp Lys Pro Ala
Asp Pro Ala Lys
Asp Pro Lys Ala
Glu Gly Lys Pro
Glu Gly Pro Lys
Glu Lys Gly Pro
Glu Lys Pro Gly
Glu Pro Gly Lys
Glu Pro Lys Gly
Gly Glu Lys Pro
Gly Glu Pro Lys
Gly Lys Glu Pro
Gly Lys Pro Glu
Gly Pro Glu Lys
Gly Pro Lys Glu
Ile Asn Pro Ser
Ile Asn Ser Pro
Ile Pro Asn Ser
Ile Pro Ser Asn
Ile Ser Asn Pro
Ile Ser Pro Asn
Lys Ala Asp Pro
Lys Ala Pro Asp
Lys Asp Ala Pro
Lys Asp Pro Ala
Lys Glu Gly Pro
Lys Glu Pro Gly
Lys Gly Glu Pro
Lys Gly Pro Glu
Lys Pro Ala Asp
Lys Pro Asp Ala
Lys Pro Glu Gly
Lys Pro Gly Glu
Leu Asn Pro Ser
Leu Asn Ser Pro
Leu Pro Asn Ser
Leu Pro Ser Asn
Leu Ser Asn Pro
Leu Ser Pro Asn
Asn Ile Pro Ser
Asn Ile Ser Pro
Asn Leu Pro Ser
Asn Leu Ser Pro
Asn Pro Ile Ser
Asn Pro Leu Ser
Asn Pro Ser Ile
Asn Pro Ser Leu
Asn Pro Thr Val
Asn Pro Val Thr
Asn Ser Ile Pro
Asn Ser Leu Pro
Asn Ser Pro Ile
Asn Ser Pro Leu
Asn Thr Pro Val
Asn Thr Val Pro
Asn Val Pro Thr
Asn Val Thr Pro
Pro Ala Asp Lys
Pro Ala Lys Asp
Pro Asp Ala Lys
Pro Asp Lys Ala
Pro Glu Gly Lys
Pro Glu Lys Gly
Pro Gly Glu Lys
Pro Gly Lys Glu
Pro Ile Asn Ser
Pro Ile Ser Asn
Pro Lys Ala Asp
Pro Lys Asp Ala
Pro Lys Glu Gly
Pro Lys Gly Glu
Pro Leu Asn Ser
Pro Leu Ser Asn
Pro Asn Ile Ser
Pro Asn Leu Ser
Pro Asn Ser Ile
Pro Asn Ser Leu
Pro Asn Thr Val
Pro Asn Val Thr
Pro Gln Ser Val
Pro Gln Val Ser
Pro Ser Ile Asn
Pro Ser Leu Asn
Pro Ser Asn Ile
Pro Ser Asn Leu
Pro Ser Gln Val
Pro Ser Val Gln
Pro Thr Asn Val
Pro Thr Val Asn
Pro Val Asn Thr
Pro Val Gln Ser
Pro Val Ser Gln
Pro Val Thr Asn
Gln Pro Ser Val
Gln Pro Val Ser
Gln Ser Pro Val
Gln Ser Val Pro
Gln Val Pro Ser
Gln Val Ser Pro
Ser Ile Asn Pro
Ser Ile Pro Asn
Ser Leu Asn Pro
Ser Leu Pro Asn
Ser Asn Ile Pro
Ser Asn Leu Pro
Ser Asn Pro Ile
Ser Asn Pro Leu
Ser Pro Ile Asn
Ser Pro Leu Asn
Ser Pro Asn Ile
Ser Pro Asn Leu
Ser Pro Gln Val
Ser Pro Val Gln
Ser Gln Pro Val
Ser Gln Val Pro
Ser Val Pro Gln
Ser Val Gln Pro
Thr Asn Pro Val
Thr Asn Val Pro
Thr Pro Asn Val
Thr Pro Val Asn
Thr Val Asn Pro
Thr Val Pro Asn
Val Asn Pro Thr
Val Asn Thr Pro
Val Pro Asn Thr
Val Pro Gln Ser
Val Pro Ser Gln
Val Pro Thr Asn
Val Gln Pro Ser
Val Gln Ser Pro
Val Ser Pro Gln
Val Ser Gln Pro
Val Thr Asn Pro
Val Thr Pro Asn
2-hydroxyethyl 2-methylprop-2-enoate,2-methylidenehexanoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid
C21H33O9- (429.21244680000007)
3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole
3-{2-[4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
C23H28FN3O4 (429.20637400000004)
Evobrutinib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent
7-[2(S)-[3(R)-Hydroxy-4-[3-(trifluoromethyl)phenyl]butyl]-5-oxopyrrolidin-1-yl]heptanoic acid
C22H30F3NO4 (429.21268160000005)
Sarpogrelate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
2-Amino-6-ethyl-4-(4-methoxyphenyl)-8-[(4-methoxyphenyl)methyl]-4,5-dihydropyrano[3,2-c]pyridine-3-carbonitrile
C26H27N3O3 (429.20523120000007)
1-[2-[[4,6-Bis(4-morpholinyl)-1,3,5-triazin-2-yl]oxy]ethyl]-3-phenylurea
C20H27N7O4 (429.21244220000005)
N-[1-methyl-2-[2-(4-phenyl-1-piperazinyl)ethyl]-5-benzimidazolyl]-2-furancarboxamide
4-[[[2-(1-Azepanyl)ethyl-(2-furanylmethyl)amino]-sulfanylidenemethyl]amino]benzoic acid ethyl ester
C23H31N3O3S (429.20860160000007)
2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide
C23H31N3O3S (429.20860160000007)
1-methyl-4-[2-oxo-2-(N-(phenylmethyl)anilino)ethyl]-5-pyrrolo[3,2-b]pyrrolecarboxylic acid propan-2-yl ester
C26H27N3O3 (429.20523120000007)
3-[4-[(1S,5R)-3-[(2-fluorophenyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
(3S,12Z)-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-1(15),8,12,17(26),18(23),19,24-heptaene-4,10-dione
C26H27N3O3 (429.20523120000007)
(3S,12Z)-14,14,21,21-tetramethyl-20-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.019,24]hexacosa-1(15),8,12,17(26),18,22,24-heptaene-4,10-dione
C26H27N3O3 (429.20523120000007)
2-amino-3-[[(6Z,9Z)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid
C21H35NO6S (429.21849700000007)
BML-280
BML-280 (VU0285655-1) is a potent and selective phospholipase D2 (PLD2) inhibitor. BML-280 has the ability to prevent caspase-3 cleavage and reduction in cell viability induced by high glucose. BML-280 can be used for rheumatoid arthritis research[1][2].
(1s,9s,10s,13s)-6-[(1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-8-oxa-4-azatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-triene-1,5,10,13-tetrol
6-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-8-oxa-4-azatricyclo[7.3.1.0²,⁷]trideca-2(7),3,5-triene-1,5,10,13-tetrol
3-(acetyloxy)-9,10-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-19-yl acetate
(3s)-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁸,²³]hexacosa-1(15),8,12,17,19,23,25-heptaene-4,10-dione
C26H27N3O3 (429.20523120000007)
4-{5-[(1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4,6-dihydroxypyridin-3-yl}-3,4-dihydroxycyclohexan-1-one
3-[(1s,2s,4ar,6s,8as)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-[(1r,2r,5r,6r)-2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]pyridine-2,4-diol
14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁸,²³]hexacosa-1(15),8,12,17,19,23,25-heptaene-4,10-dione
C26H27N3O3 (429.20523120000007)